DURECT CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.16 USD | +17.17% |
|
+24.56% | +96.61% |
| 03-27 | Transcript : DURECT Corporation, Q4 2023 Earnings Call, Mar 27, 2024 | |
| 03-27 | DURECT Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar DURECT Corporation
f22ac265.x73-v0GQ4Zk4sXKSMPTGCg54uTaAFhD1iWh6zpHCmfk.kve5_A791OthgyPTXJ6KQGoU31TnRyHHsTEPr_Kb_82f98v5NMGv9ADrEQ~8f6d239aa4a38021f3f6b79f1c50e112
Upcoming events on DURECT Corporation
Past events on DURECT Corporation
| 27/03/2024 20:30 | Q4 2023 Earnings Call |
| 27/03/2024 20:05 | Q4 2023 Earnings Release |
| 14/02/2024 15:40 | Oppenheimer Healthcare Life Sciences Conference |
| 13/11/2023 21:30 | Q3 2023 Earnings Call |
| 13/11/2023 21:05 | Q3 2023 Earnings Release |
| 07/11/2023 22:00 | Business Update Call |
| 27/09/2023 21:45 | Cantor Global Healthcare Conference |
| 11/09/2023 15:30 | H.C. Wainwright Global Investment Conference |
| 09/08/2023 21:30 | Q2 2023 Earnings Call |
| 09/08/2023 21:05 | Q2 2023 Earnings Release |
| 21/06/2023 17:00 | Annual General Meeting |
| 16/05/2023 17:00 | Investor Meeting - Key Opinion Leader |
| 08/05/2023 21:30 | Q1 2023 Earnings Call |
| 08/05/2023 21:05 | Q1 2023 Earnings Release |
| 02/05/2023 15:00 | H.C. Wainwright BioConnect Investor Conference |
| 15/03/2023 18:00 | Oppenheimer Healthcare Conference |
| 07/03/2023 21:30 | Q4 2022 Earnings Call |
| 07/03/2023 21:05 | Q4 2022 Earnings Release |
| 05/12/2022 | Reverse Split: 1 of 10 |
| 21/11/2022 | Extraordinary Shareholders Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 29,6 29,8 -0.84% | 30,1 40,4 -25.4% | 14,0 8,79 59.07% | 19,3 19,5 -0.91% | 8,55 8,58 -0.38% | 10,7 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -19,2 -18,2 -5.19% | -12,6 -6,40 -97.24% | -34,3 -38,3 10.59% | -35,1 -35,6 1.32% | -36,9 -40,3 8.41% | -35,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -20,6 -19,9 -3.36% | -14,3 -6,90 -107.67% | -36,3 -40,2 9.74% | -35,3 -37,4 5.43% | -27,6 -37,8 26.82% | -30,4 |
|
Net income Million USD | Released Forecast Spread | -20,6 -19,9 -3.36% | -0,58 -8,07 92.78% | -36,3 -40,2 9.74% | -35,3 -37,3 5.36% | -27,6 -37,9 27.16% | -37,2 |
|
EPS USD | Released Forecast Spread | -1,20 -1,14 -5.26% | 0,00 -0,40 - | -1,60 -1,80 11.11% | -1,55 -1,15 -34.78% | -1,05 -1,46 28.25% | -1,08 |
| Announcement Date | 03/03/20 | 04/03/21 | 07/03/22 | 07/03/23 | 27/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 7,30 2,10 247.48% | 1,92 2,28 -16.13% | 2,08 3,84 -45.98% | 12,0 13,0 -7.78% | 3,32 3,48 -4.78% | 2,05 3,19 -35.52% | 2,08 3,16 -34.12% | 1,74 2,52 -30.74% | 2,67 2,70 -1.22% | 2,73 | 2,83 | 2,93 | 3,13 |
|
EBIT Million USD | Released Forecast Spread | -6,51 -10,6 38.53% | -10,4 -11,9 13.21% | -11,1 -10,4 -7.1% | -2,13 -2,29 6.85% | -11,5 -12,0 3.88% | -11,0 -12,5 11.98% | -10,1 -11,2 10.09% | -9,56 -10,6 10.17% | -6,25 -9,64 35.12% | -6,34 | -6,24 | -7,64 | -8,93 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,01 -10,9 35.95% | -10,8 -12,3 11.79% | -11,6 -10,9 -6.27% | -2,47 -2,81 12.02% | -10,5 -12,5 16.15% | -12,0 -12,9 7.16% | -11,2 -11,7 4.18% | -3,02 -10,8 71.96% | -1,44 -8,88 83.78% | -6,65 | -6,55 | -7,95 | -9,24 |
|
Net income Million USD | Released Forecast Spread | -7,01 -10,9 35.95% | -10,8 -12,3 11.79% | -11,6 -10,9 -6.27% | -2,47 -2,81 12.02% | -10,5 -12,5 16.15% | -12,0 -12,9 7.16% | -11,2 -11,7 4.18% | -3,02 -11,0 72.47% | -1,44 -9,96 85.53% | -6,65 | -6,55 | -7,95 | -9,24 |
|
EPS USD | Released Forecast Spread | -0,30 -0,50 40% | -0,50 -0,53 6.25% | -0,50 -0,47 -7.14% | -0,10 -0,10 0% | -0,46 -0,55 15.85% | -0,50 -0,53 5.06% | -0,46 -0,48 4.83% | -0,11 -0,41 73.39% | -0,05 -0,36 86.11% | -0,22 | -0,19 | -0,23 | -0,27 |
| Announcement Date | 07/03/22 | 04/05/22 | 04/08/22 | 02/11/22 | 07/03/23 | 08/05/23 | 09/08/23 | 13/11/23 | 27/03/24 | - | - | - | - |
More events
Past sector events for DURECT Corporation
| 03/05/2024 12:00 | GH RESEARCH PLC: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | ZYMEWORKS INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:02 | ARDELYX, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 02/05/2024 21:00 | ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release |
| 02/05/2024 16:00 | GENMAB A/S: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | GERON CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- DRRX Stock
- Calendar DURECT Corporation
